Semler Scientific Inc
NASDAQ:SMLR
Balance Sheet
Balance Sheet Decomposition
Semler Scientific Inc
Current Assets | 65.9m |
Cash & Short-Term Investments | 57.2m |
Receivables | 6.1m |
Other Current Assets | 2.6m |
Non-Current Assets | 12.1m |
Long-Term Investments | 5.9m |
PP&E | 3.2m |
Other Non-Current Assets | 3.1m |
Current Liabilities | 6.2m |
Accounts Payable | 402k |
Accrued Liabilities | 4.6m |
Other Current Liabilities | 1.2m |
Non-Current Liabilities | 70k |
Other Non-Current Liabilities | 70k |
Balance Sheet
Semler Scientific Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
4
|
0
|
1
|
1
|
3
|
8
|
22
|
37
|
23
|
57
|
|
Cash |
4
|
0
|
1
|
1
|
3
|
8
|
22
|
37
|
23
|
57
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
0
|
|
Total Receivables |
0
|
1
|
1
|
1
|
3
|
3
|
3
|
4
|
4
|
6
|
|
Accounts Receivables |
0
|
1
|
1
|
1
|
3
|
3
|
3
|
4
|
4
|
6
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Other Current Assets |
2
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
1
|
2
|
|
Total Current Assets |
7
|
2
|
2
|
3
|
6
|
11
|
27
|
46
|
49
|
66
|
|
PP&E Net |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
|
PP&E Gross |
1
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
3
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
6
|
6
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
5
|
3
|
2
|
5
|
3
|
|
Total Assets |
8
N/A
|
3
-59%
|
3
0%
|
4
+38%
|
8
+82%
|
18
+137%
|
35
+89%
|
51
+46%
|
63
+24%
|
78
+25%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
|
Accrued Liabilities |
1
|
2
|
2
|
3
|
3
|
4
|
3
|
4
|
5
|
5
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
2
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Total Current Liabilities |
4
|
4
|
3
|
5
|
4
|
5
|
5
|
5
|
7
|
6
|
|
Long-Term Debt |
0
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
4
N/A
|
4
+2%
|
6
+44%
|
7
+14%
|
4
-48%
|
5
+48%
|
5
-7%
|
5
+6%
|
7
+37%
|
6
-11%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
14
|
22
|
25
|
26
|
21
|
6
|
8
|
25
|
39
|
60
|
|
Additional Paid In Capital |
17
|
21
|
22
|
24
|
26
|
19
|
22
|
21
|
16
|
12
|
|
Total Equity |
3
N/A
|
1
N/A
|
3
-173%
|
3
+12%
|
4
N/A
|
13
+211%
|
30
+128%
|
46
+53%
|
56
+22%
|
72
+29%
|
|
Total Liabilities & Equity |
8
N/A
|
3
-59%
|
3
0%
|
4
+38%
|
8
+82%
|
18
+137%
|
35
+89%
|
51
+46%
|
63
+24%
|
78
+25%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
5
|
5
|
5
|
6
|
6
|
7
|
7
|
7
|
7
|
7
|